Ali Pay Intelligent Navigation Applet-aided Pre-hospital Triage for Non-emergency Medical Service Patients With Acute Ischemic Stroke
Launched by SECOND AFFILIATED HOSPITAL, SCHOOL OF MEDICINE, ZHEJIANG UNIVERSITY · Sep 23, 2024
Trial Information
Current as of August 21, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is focused on improving how quickly patients with acute ischemic stroke (a type of stroke caused by a blockage in blood flow to the brain) receive treatment. The researchers are developing an intelligent navigation applet that will be available on the popular Ali Pay app, which many people in China already use. This app is designed to help patients recognize the signs of a stroke, learn about the condition, and find the best hospitals for treatment. The goal is to reduce the time it takes for patients to get to the hospital after experiencing a stroke, ultimately improving their chances of recovery.
To participate in this trial, individuals must be diagnosed with acute ischemic stroke and should be seeking reperfusion therapy (a treatment to restore blood flow) within 24 hours of their symptoms starting. However, patients who are taken to the hospital by emergency medical services or who have strokes while already in the hospital are not eligible. Although the trial is not yet recruiting participants, those involved can expect to use the app to navigate their care more efficiently and potentially see better outcomes from their treatment.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Patients diagnosed as acute ischemic stroke undergoing reperfusion therapy within 24 hours of onset
- Exclusion Criteria:
- • Patients transported to hospitals via emergency medical service
- • Patients with in-hospital stroke
About Second Affiliated Hospital, School Of Medicine, Zhejiang University
The Second Affiliated Hospital of Zhejiang University School of Medicine is a leading clinical research institution dedicated to advancing healthcare through innovative medical practices and rigorous scientific inquiry. With a robust infrastructure and a multidisciplinary team of experienced researchers and clinicians, the hospital is committed to conducting high-quality clinical trials that address critical health challenges. As an integral part of Zhejiang University, the hospital leverages academic expertise and cutting-edge technology to foster collaboration in research, education, and patient care, ultimately aiming to improve patient outcomes and contribute to the global medical community.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Shaoxing, Zhejing, China
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported